IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination high-quality research in area science. With long tradition wide readership, dedicated making positive contributions academics, corporate libraries as well readers authors. All editors will provide best service for researchers, allowing them have easy smooth...

Some diseases including tumor, genetic diseases and uncured diseases in nerve, endocrine, cardiovascular systems require physicians to address a question about effective prevention and treatment[1]. This is why physicians should apply for new techniques available as soon as possible. Now some important discoveries in enhancing the therapeutic effect have emerged in clinical fields such as “pers...

We have developed a novel approach in cancer immunotherapy, the personalized peptide vaccination (PPV), in which human leukocyte antigen (HLA)-matched peptides are selected on the basis of preexisting host immunity before vaccination. Recently, we demonstrated the feasibility of PPV in previously treated patients with advanced colorectal cancer, thus warranting further clinical development of t...

Purpose To review the usefulness of local and systemic inflammatory biomarkers of diabetic retinopathy (DR) to implement a more personalized treatment. Methods An integrated research (from ophthalmologist and diabetologist point of view) of most significant literature on serum, vitreous, and aqueous humor (AH) biochemical biomarkers related to inflammation at early and advanced stages of DR (...